EUVIMEDEUVIMED entdecken
Crossref

Underreporting of basophil count by automated analyzer Sysmex XN 1000 in chronic myeloid leukemia: A diagnostic concern

Priyavadhana Balasubramanian, Kavya UR, Subhajit Hajra, Kaashvi Gupta, Neha Singh, Arvind Kumar Gupta, Harish Chandra

Journal of Laboratory Physicians · 19.08.2026 · 1-5

DOI: 10.25259/jlp_79_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Laboratory Physicians, online erschienen am 19.08.2026. Verfasst von Priyavadhana Balasubramanian und 6 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study compared the basophil counts (BC) on the automated analyzer Sysmex XN1000 (XN 1000) with manual differential count (DC). Materials and Methods: The study was conducted over a period of 2 years and included 77 diagnosed chronic myeloid leukemia (CML) cases. We compared the basophil percentages provided by XN 1000 with those of manual DC on peripheral blood smear (PBS). Manual DC was done by two hematopathologists on 200 cells, and the mean values were taken. Manual DC was considered the gold standard for comparison. Statistical analysis: Statistical analysis was done on R statistical software, version 4.1.

Results

Seventy-seven patients of CML were included in the study. Mean basophil percentage (%) by XN1000 was 3.96% while the mean basophil % by manual DC was 7.07%. Pearson correlation between the two values was 0.249 with a significant p value (0.03). It was evident that the basophil percentage by automated analyzer was significantly lower compared to that obtained by manual counts. There was a mean difference (bias) of −3.11, suggesting that Sysmex XN 1000 can underestimate by ~3.1% when compared with the manual method.

Conclusions

Automated analyzers (Sysmex XN 1000) underestimate the percentage of basophils in CML. The BC should be done manually on PBS for all cases of suspected CML since BC has a significant role in deciding the clinical management in CML patients.

Zitieren

APA

Balasubramanian, P., UR, K., Hajra, S., Gupta, K., Singh, N., Gupta, A. K., & Chandra, H. (2026). Underreporting of basophil count by automated analyzer Sysmex XN 1000 in chronic myeloid leukemia: A diagnostic concern. Journal of Laboratory Physicians, 0, 1-5. https://doi.org/10.25259/jlp_79_2026

Vancouver

Balasubramanian P, UR K, Hajra S, Gupta K, Singh N, Gupta AK, et al. Underreporting of basophil count by automated analyzer Sysmex XN 1000 in chronic myeloid leukemia: A diagnostic concern. Journal of Laboratory Physicians. 2026;0:1-5. doi:10.25259/jlp_79_2026

BibTeX
@article{Balasubramanian2026,
  author = {Balasubramanian, Priyavadhana and UR, Kavya and Hajra, Subhajit and Gupta, Kaashvi and Singh, Neha and Gupta, Arvind Kumar and Chandra, Harish},
  title = {Underreporting of basophil count by automated analyzer Sysmex XN 1000 in chronic myeloid leukemia: A diagnostic concern},
  journal = {Journal of Laboratory Physicians},
  year = {2026},
  volume = {0},
  pages = {1--5},
  doi = {10.25259/jlp_79_2026}
}
Kostenlos starten →